KONINKLIJKE PHILIPS NV (1PHIA.MI) Stock Fundamental Analysis
BIT:1PHIA - Euronext Milan - NL0000009538 - Common Stock - Currency: EUR
Taking everything into account, 1PHIA scores 3 out of 10 in our fundamental rating. 1PHIA was compared to 61 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of 1PHIA have multiple concerns. 1PHIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year 1PHIA was profitable.
In the past year 1PHIA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: 1PHIA reported negative net income in multiple years.
1PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.42%, 1PHIA is doing worse than 62.30% of the companies in the same industry.
1PHIA has a Return On Equity of -5.85%. This is in the lower half of the industry: 1PHIA underperforms 62.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROIC | N/A |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of 1PHIA has declined.
Looking at the Gross Margin, with a value of 43.13%, 1PHIA is doing worse than 72.13% of the companies in the same industry.
In the last couple of years the Gross Margin of 1PHIA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for 1PHIA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% |
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
1PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
1PHIA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for 1PHIA has been increased compared to 5 years ago.
The debt/assets ratio for 1PHIA is higher compared to a year ago.
2.2 Solvency
1PHIA has an Altman-Z score of 1.59. This is a bad value and indicates that 1PHIA is not financially healthy and even has some risk of bankruptcy.
1PHIA's Altman-Z score of 1.59 is in line compared to the rest of the industry. 1PHIA outperforms 47.54% of its industry peers.
The Debt to FCF ratio of 1PHIA is 8.68, which is on the high side as it means it would take 1PHIA, 8.68 years of fcf income to pay off all of its debts.
1PHIA has a Debt to FCF ratio (8.68) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.59 indicates that 1PHIA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.59, 1PHIA is not doing good in the industry: 65.57% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Altman-Z | 1.59 |
ROIC/WACCN/A
WACC6.26%
2.3 Liquidity
1PHIA has a Current Ratio of 1.23. This is a normal value and indicates that 1PHIA is financially healthy and should not expect problems in meeting its short term obligations.
1PHIA has a Current ratio of 1.23. This is in the lower half of the industry: 1PHIA underperforms 65.57% of its industry peers.
A Quick Ratio of 0.84 indicates that 1PHIA may have some problems paying its short term obligations.
1PHIA has a Quick ratio of 0.84. This is in the lower half of the industry: 1PHIA underperforms 62.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.56% over the past year.
1PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
The Revenue has decreased by -0.81% in the past year.
1PHIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)6.56%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%-8.18%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-7.91%
3.2 Future
Based on estimates for the next years, 1PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.99% on average per year.
1PHIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.55% yearly.
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.99%
Revenue Next Year1.15%
Revenue Next 2Y2.61%
Revenue Next 3Y3.12%
Revenue Next 5Y3.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.87, which indicates a correct valuation of 1PHIA.
Based on the Price/Earnings ratio, 1PHIA is valued cheaply inside the industry as 83.61% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of 1PHIA to the average of the S&P500 Index (25.82), we can say 1PHIA is valued slightly cheaper.
A Price/Forward Earnings ratio of 12.52 indicates a correct valuation of 1PHIA.
Based on the Price/Forward Earnings ratio, 1PHIA is valued a bit cheaper than 78.69% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. 1PHIA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.87 | ||
| Fwd PE | 12.52 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1PHIA is valued a bit cheaper than the industry average as 60.66% of the companies are valued more expensively.
1PHIA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1PHIA is cheaper than 78.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.05 | ||
| EV/EBITDA | 18.48 |
4.3 Compensation for Growth
1PHIA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as 1PHIA's earnings are expected to grow with 12.13% in the coming years.
PEG (NY)1.6
PEG (5Y)N/A
EPS Next 2Y11.54%
EPS Next 3Y12.13%
5. Dividend
5.1 Amount
No dividends for 1PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1PHIA (5/15/2025, 7:00:00 PM)
21.58
-0.35 (-1.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners48.26%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap20.28B
Analysts73.08
Price Target28.59 (32.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP-0.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.27%
Min EPS beat(2)-16.56%
Max EPS beat(2)-11.97%
EPS beat(4)0
Avg EPS beat(4)-12.16%
Min EPS beat(4)-16.56%
Max EPS beat(4)-6.96%
EPS beat(8)2
Avg EPS beat(8)0.79%
EPS beat(12)3
Avg EPS beat(12)3.3%
EPS beat(16)5
Avg EPS beat(16)1.18%
Revenue beat(2)0
Avg Revenue beat(2)-4.13%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-3.04%
Revenue beat(4)0
Avg Revenue beat(4)-3.42%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-2.46%
Revenue beat(8)1
Avg Revenue beat(8)-2.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.69%
Revenue beat(16)2
Avg Revenue beat(16)-2.44%
PT rev (1m)-1.2%
PT rev (3m)-1.6%
EPS NQ rev (1m)-12.16%
EPS NQ rev (3m)-23.18%
EPS NY rev (1m)-2.3%
EPS NY rev (3m)-1.51%
Revenue NQ rev (1m)-2.06%
Revenue NQ rev (3m)-4.78%
Revenue NY rev (1m)-2.65%
Revenue NY rev (3m)-3.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.87 | ||
| Fwd PE | 12.52 | ||
| P/S | 1.13 | ||
| P/FCF | 23.05 | ||
| P/OCF | 13.04 | ||
| P/B | 1.69 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.48 |
EPS(TTM)1.36
EY6.3%
EPS(NY)1.72
Fwd EY7.99%
FCF(TTM)0.94
FCFY4.34%
OCF(TTM)1.66
OCFY7.67%
SpS19.17
BVpS12.77
TBVpS-1.45
PEG (NY)1.6
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% | ||
| FCFM | 4.88% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Debt/EBITDA | 5.15 | ||
| Cap/Depr | 48.63% | ||
| Cap/Sales | 3.75% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 112.67% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.59 |
F-Score6
WACC6.26%
ROIC/WACCN/A
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.56%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%-8.18%
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.99%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-7.91%
Revenue Next Year1.15%
Revenue Next 2Y2.61%
Revenue Next 3Y3.12%
Revenue Next 5Y3.55%
EBIT growth 1Y91.51%
EBIT growth 3Y-0.63%
EBIT growth 5Y-7.54%
EBIT Next Year57.53%
EBIT Next 3Y22.84%
EBIT Next 5YN/A
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%